![J6Q J6Q](https://data.pdbj.org/pdbjplus/data/cc/svg/J6Q.svg) | J6Q | Name: | (3~{S})-3-(4-chloranyl-3-methyl-phenyl)-3-(1-methylbenzotriazol-5-yl)propanoic acid | Formula: | C17 H16 Cl N3 O2 | SMILES: | Cn1nnc2cc(ccc12)[CH](CC(O)=O)c3ccc(Cl)c(C)c3 | InChi: | InChI=1S/C17H16ClN3O2/c1-10-7-11(3-5-14(10)18)13(9-17(22)23)12-4-6-16-15(8-12)19-20-21(16)2/h3-8,13H,9H2,1-2H3,(H,22,23)/t13-/m0/s1 | Definition date: | 2019-02-08 | Last modified: | 2019-04-19 | Release date: | 2019-04-24 | Identifier: | (3~{S})-3-(4-chloranyl-3-methyl-phenyl)-3-(1-methylbenzotriazol-5-yl)propanoic acid |
|
![J6T J6T](https://data.pdbj.org/pdbjplus/data/cc/svg/J6T.svg) | J6T | Name: | 2-[2-[[3-[3-[(1~{S})-1-azanyl-2-oxidanyl-ethyl]phenyl]phenyl]methoxy]phenyl]ethanoic acid | Formula: | C23 H23 N O4 | SMILES: | N[CH](CO)c1cccc(c1)c2cccc(COc3ccccc3CC(O)=O)c2 | InChi: | InChI=1S/C23H23NO4/c24-21(14-25)19-9-4-8-18(12-19)17-7-3-5-16(11-17)15-28-22-10-2-1-6-20(22)13-23(26)27/h1-12,21,25H,13-15,24H2,(H,26,27)/t21-/m1/s1 | Definition date: | 2019-02-08 | Last modified: | 2019-04-19 | Release date: | 2019-04-24 | Identifier: | 2-[2-[[3-[3-[(1~{S})-1-azanyl-2-oxidanyl-ethyl]phenyl]phenyl]methoxy]phenyl]ethanoic acid |
|
![J7B J7B](https://data.pdbj.org/pdbjplus/data/cc/svg/J7B.svg) | J7B | Name: | 2-[2-[[3-[3-(aminomethyl)phenyl]phenyl]carbonylamino]phenyl]ethanoic acid | Formula: | C22 H20 N2 O3 | SMILES: | NCc1cccc(c1)c2cccc(c2)C(=O)Nc3ccccc3CC(O)=O | InChi: | InChI=1S/C22H20N2O3/c23-14-15-5-3-7-16(11-15)17-8-4-9-19(12-17)22(27)24-20-10-2-1-6-18(20)13-21(25)26/h1-12H,13-14,23H2,(H,24,27)(H,25,26) | Definition date: | 2019-02-08 | Last modified: | 2019-04-19 | Release date: | 2019-04-24 | Identifier: | 2-[2-[[3-[3-(aminomethyl)phenyl]phenyl]carbonylamino]phenyl]ethanoic acid |
|
![J8H J8H](https://data.pdbj.org/pdbjplus/data/cc/svg/J8H.svg) | J8H | Name: | (3~{S})-3-[3-[[1,1-bis(oxidanylidene)-3,4-dihydro-5,1$l^{6},2-benzoxathiazepin-2-yl]methyl]-4-methyl-phenyl]-3-(7-methoxy-1-methyl-benzotriazol-5-yl)propanoic acid | Formula: | C27 H28 N4 O6 S | SMILES: | COc1cc(cc2nnn(C)c12)[CH](CC(O)=O)c3ccc(C)c(CN4CCOc5ccccc5[S]4(=O)=O)c3 | InChi: | InChI=1S/C27H28N4O6S/c1-17-8-9-18(12-20(17)16-31-10-11-37-23-6-4-5-7-25(23)38(31,34)35)21(15-26(32)33)19-13-22-27(24(14-19)36-3)30(2)29-28-22/h4-9,12-14,21H,10-11,15-16H2,1-3H3,(H,32,33)/t21-/m0/s1 | Definition date: | 2019-02-09 | Last modified: | 2019-04-19 | Release date: | 2019-04-24 | Identifier: | (3~{S})-3-[3-[[1,1-bis(oxidanylidene)-3,4-dihydro-5,1$l^{6},2-benzoxathiazepin-2-yl]methyl]-4-methyl-phenyl]-3-(7-methoxy-1-methyl-benzotriazol-5-yl)propanoic acid |
|
![JDV JDV](https://data.pdbj.org/pdbjplus/data/cc/svg/JDV.svg) | JDV | Name: | (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]carbamate | Formula: | C33 H41 F N4 O7 S2 | SMILES: | C21OCC3C(C(CO1)C2C3)OC(NC(C(CN(CC(C)C)S(c4cc5c(cc4)nc(s5)NC6CC6)(=O)=O)O)Cc7ccc(F)cc7)=O | InChi: | InChI=1S/C33H41FN4O7S2/c1-18(2)14-38(47(41,42)23-9-10-26-29(13-23)46-32(36-26)35-22-7-8-22)15-28(39)27(11-19-3-5-21(34)6-4-19)37-33(40)45-30-20-12-24-25(30)17-44-31(24)43-16-20/h3-6,9-10,13,18,20,22,24-25,27-28,30-31,39H,7-8,11-12,14-17H2,1-2H3,(H,35,36)(H,37,40)/t20-,24-,25-,27+,28-,30+,31+/m1/s1 | Definition date: | 2018-09-05 | Last modified: | 2019-04-19 | Release date: | 2019-04-24 | Identifier: | (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]carbamate |
|
![JDY JDY](https://data.pdbj.org/pdbjplus/data/cc/svg/JDY.svg) | JDY | Name: | (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(3-fluorophenyl)-3-hydroxybutan-2-yl]carbamate | Formula: | C33 H41 F N4 O7 S2 | SMILES: | C21OCC3C(C(CO1)C2C3)OC(NC(C(CN(CC(C)C)S(c4cc5c(cc4)nc(s5)NC6CC6)(=O)=O)O)Cc7cccc(c7)F)=O | InChi: | InChI=1S/C33H41FN4O7S2/c1-18(2)14-38(47(41,42)23-8-9-26-29(13-23)46-32(36-26)35-22-6-7-22)15-28(39)27(11-19-4-3-5-21(34)10-19)37-33(40)45-30-20-12-24-25(30)17-44-31(24)43-16-20/h3-5,8-10,13,18,20,22,24-25,27-28,30-31,39H,6-7,11-12,14-17H2,1-2H3,(H,35,36)(H,37,40)/t20-,24-,25-,27+,28-,30+,31+/m1/s1 | Definition date: | 2018-09-05 | Last modified: | 2019-04-19 | Release date: | 2019-04-24 | Identifier: | (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(3-fluorophenyl)-3-hydroxybutan-2-yl]carbamate |
|
![JKW JKW](https://data.pdbj.org/pdbjplus/data/cc/svg/JKW.svg) | JKW | Name: | 2-[(1-methylpiperidin-4-yl)methylamino]-5-[[2-[4-(trifluoromethyloxy)phenyl]-1,3-thiazol-4-yl]methyl]-1,3-thiazol-4-one | Formula: | C21 H23 F3 N4 O2 S2 | SMILES: | CN1CCC(CC1)CNC2=NC(=O)C(=[SH]2)Cc3csc(n3)c4ccc(OC(F)(F)F)cc4 | InChi: | InChI=1S/C21H23F3N4O2S2/c1-28-8-6-13(7-9-28)11-25-20-27-18(29)17(32-20)10-15-12-31-19(26-15)14-2-4-16(5-3-14)30-21(22,23)24/h2-5,12-13,32H,6-11H2,1H3,(H,25,27,29) | Definition date: | 2019-03-08 | Last modified: | 2019-04-19 | Release date: | 2019-04-24 | Identifier: | 2-[(1-methylpiperidin-4-yl)methylamino]-5-[[2-[4-(trifluoromethyloxy)phenyl]-1,3-thiazol-4-yl]methyl]-1,3-thiazol-4-one |
|
![EP8 EP8](https://data.pdbj.org/pdbjplus/data/cc/svg/EP8.svg) | EP8 | Name: | 5-[3-(1~{H}-indol-3-yl)propoxy]-1-phenyl-pyrazole-4-carboxylic acid | Formula: | C21 H19 N3 O3 | SMILES: | OC(=O)c1cnn(c2ccccc2)c1OCCCc3c[nH]c4ccccc34 | InChi: | InChI=1S/C21H19N3O3/c25-21(26)18-14-23-24(16-8-2-1-3-9-16)20(18)27-12-6-7-15-13-22-19-11-5-4-10-17(15)19/h1-5,8-11,13-14,22H,6-7,12H2,(H,25,26) | Definition date: | 2018-04-06 | Last modified: | 2019-04-19 | Release date: | 2019-04-24 | Identifier: | 5-[3-(1~{H}-indol-3-yl)propoxy]-1-phenyl-pyrazole-4-carboxylic acid |
|
![EQ5 EQ5](https://data.pdbj.org/pdbjplus/data/cc/svg/EQ5.svg) | EQ5 | Name: | 3-indol-1-ylpropanoic acid | Formula: | C11 H11 N O2 | SMILES: | OC(=O)CCn1ccc2ccccc12 | InChi: | InChI=1S/C11H11NO2/c13-11(14)6-8-12-7-5-9-3-1-2-4-10(9)12/h1-5,7H,6,8H2,(H,13,14) | Definition date: | 2018-04-09 | Last modified: | 2019-04-19 | Release date: | 2019-04-24 | Identifier: | 3-indol-1-ylpropanoic acid |
|
![EQQ EQQ](https://data.pdbj.org/pdbjplus/data/cc/svg/EQQ.svg) | EQQ | Name: | Ruthenium (bis-(tetraazaphenanthrene)) (11,12-dicyano-dipyridophenazine) | Formula: | C40 H20 N14 Ru | SMILES: | [Ru].N#Cc1cc2nc3c4cccnc4c5ncccc5c3nc2cc1C#N.c6cnc7c(ccc8nccnc78)n6.c9cnc%10c(ccc%11nccnc%10%11)n9 | InChi: | InChI=1S/C20H8N6.2C10H6N4.Ru/c21-9-11-7-15-16(8-12(11)10-22)26-20-14-4-2-6-24-18(14)17-13(19(20)25-15)3-1-5-23-17 | Definition date: | 2018-04-10 | Last modified: | 2019-04-19 | Release date: | 2019-04-24 |
|
![EU5 EU5](https://data.pdbj.org/pdbjplus/data/cc/svg/EU5.svg) | EU5 | Name: | (2~{S})-~{N}-[[2-(aminomethyl)-5-chloranyl-phenyl]methyl]-1-[(2~{S})-5-carbamimidamido-2-[(phenylmethyl)sulfonylamino]pentanoyl]pyrrolidine-2-carboxamide | Formula: | C26 H36 Cl N7 O4 S | SMILES: | NCc1ccc(Cl)cc1CNC(=O)[CH]2CCCN2C(=O)[CH](CCCNC(N)=N)N[S](=O)(=O)Cc3ccccc3 | InChi: | InChI=1S/C26H36ClN7O4S/c27-21-11-10-19(15-28)20(14-21)16-32-24(35)23-9-5-13-34(23)25(36)22(8-4-12-31-26(29)30)33-39(37,38)17-18-6-2-1-3-7-18/h1-3,6-7,10-11,14,22-23,33H,4-5,8-9,12-13,15-17,28H2,(H,32,35)(H4,29,30,31)/t22-,23-/m0/s1 | Definition date: | 2018-04-16 | Last modified: | 2019-04-19 | Release date: | 2019-04-24 | Identifier: | (2~{S})-~{N}-[[2-(aminomethyl)-5-chloranyl-phenyl]methyl]-1-[(2~{S})-5-carbamimidamido-2-[(phenylmethyl)sulfonylamino]pentanoyl]pyrrolidine-2-carboxamide |
|
![CHL CHL](https://data.pdbj.org/pdbjplus/data/cc/svg/CHL.svg) | CHL | Name: | CHLOROPHYLL B | Formula: | C55 H70 Mg N4 O6 | SMILES: | CCC1=C(C=O)C2=Cc3n4c(C=C5[CH](C)[CH](CCC(=O)OCC=C(C)CCC[CH](C)CCC[CH](C)CCCC(C)C)C6=[N+]5[Mg]47[N]8C(=CC1=[N+]27)C(=C9C(=O)[CH](C(=O)OC)C6=C89)C)c(C)c3C=C | InChi: | InChI=1S/C55H71N4O6.Mg/c1-12-38-35(8)42-27-43-36(9)40(23-24-48(61)65-26-25-34(7)22-16-21-33(6)20-15-19-32(5)18-14-17-31(3)4)52(58-43)50-51(55(63)64-11)54(62)49-37(10)44(59-53(49)50)28-46-39(13-2)41(30-60)47(57-46)29-45(38)56-42 | Definition date: | 1999-07-08 | Last modified: | 2019-04-16 |
|
![HJ8 HJ8](https://data.pdbj.org/pdbjplus/data/cc/svg/HJ8.svg) | HJ8 | Name: | (2~{S})-2-azanyl-3-(3-ethyl-5-oxidanyl-1,2,3-triazol-4-yl)propanoic acid | Formula: | C7 H12 N4 O3 | SMILES: | CCn1nnc(O)c1C[CH](N)C(O)=O | InChi: | InChI=1S/C7H12N4O3/c1-2-11-5(6(12)9-10-11)3-4(8)7(13)14/h4,12H,2-3,8H2,1H3,(H,13,14)/t4-/m0/s1 | Definition date: | 2018-12-07 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | (2~{S})-2-azanyl-3-(3-ethyl-5-oxidanyl-1,2,3-triazol-4-yl)propanoic acid |
|
![HJH HJH](https://data.pdbj.org/pdbjplus/data/cc/svg/HJH.svg) | HJH | Name: | (2~{S})-2-azanyl-3-(2-methyl-5-oxidanyl-1,2,3-triazol-4-yl)propanoic acid | Formula: | C6 H10 N4 O3 | SMILES: | Cn1nc(O)c(C[CH](N)C(O)=O)n1 | InChi: | InChI=1S/C6H10N4O3/c1-10-8-4(5(11)9-10)2-3(7)6(12)13/h3H,2,7H2,1H3,(H,9,11)(H,12,13)/t3-/m0/s1 | Definition date: | 2018-12-10 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | (2~{S})-2-azanyl-3-(2-methyl-5-oxidanyl-1,2,3-triazol-4-yl)propanoic acid |
|
![HQ5 HQ5](https://data.pdbj.org/pdbjplus/data/cc/svg/HQ5.svg) | HQ5 | Name: | 5'-O-(N-(L-Leucyl)-Sulfamoyl)Cytidine | Formula: | C15 H25 N5 O8 S | SMILES: | CC(C)C[CH](N)C(=O)N[S](=O)(=O)OC[CH]1O[CH]([CH](O)[CH]1O)N2C=CC(=NC2=O)N | InChi: | InChI=1S/C15H25N5O8S/c1-7(2)5-8(16)13(23)19-29(25,26)27-6-9-11(21)12(22)14(28-9)20-4-3-10(17)18-15(20)24/h3-4,7-9,11-12,14,21-22H,5-6,16H2,1-2H3,(H,19,23)(H2,17,18,24)/t8-,9+,11+,12+,14+/m0/s1 | Definition date: | 2018-12-14 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl ~{N}-[(2~{S})-2-azanyl-4-methyl-pentanoyl]sulfamate |
|
![FYS FYS](https://data.pdbj.org/pdbjplus/data/cc/svg/FYS.svg) | FYS | Name: | 4,4',4''-[(2R)-butane-1,1,2-triyl]triphenol | Formula: | C22 H22 O3 | SMILES: | CCC(c1ccc(O)cc1)C(c2ccc(O)cc2)c3ccc(cc3)O | InChi: | InChI=1S/C22H22O3/c1-2-21(15-3-9-18(23)10-4-15)22(16-5-11-19(24)12-6-16)17-7-13-20(25)14-8-17/h3-14,21-25H,2H2,1H3/t21-/m0/s1 | Definition date: | 2018-04-25 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | 4,4',4''-[(2R)-butane-1,1,2-triyl]triphenol |
|
![L3U L3U](https://data.pdbj.org/pdbjplus/data/cc/svg/L3U.svg) | L3U | Name: | [(2~{R},3~{S},4~{R},5~{R})-5-[3-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl ~{N}-[(2~{S})-2-azanyl-4-methyl-pentanoyl]sulfamate | Formula: | C16 H26 N4 O9 S | SMILES: | CC(C)C[CH](N)C(=O)N[S](=O)(=O)OC[CH]1O[CH]([CH](O)[CH]1O)N2C=CC(=O)N(C)C2=O | InChi: | InChI=1S/C16H26N4O9S/c1-8(2)6-9(17)14(24)18-30(26,27)28-7-10-12(22)13(23)15(29-10)20-5-4-11(21)19(3)16(20)25/h4-5,8-10,12-13,15,22-23H,6-7,17H2,1-3H3,(H,18,24)/t9-,10+,12+,13+,15+/m0/s1 | Definition date: | 2018-12-17 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-[3-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl ~{N}-[(2~{S})-2-azanyl-4-methyl-pentanoyl]sulfamate |
|
![HZD HZD](https://data.pdbj.org/pdbjplus/data/cc/svg/HZD.svg) | HZD | Name: | 4-[(3-{2,16-dioxo-20-[(3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-6,9,12-trioxa-3,15-diazaicosan-1-yl}-1,3-benzothiazol-3-ium-2-yl)methyl]-1-methylquinolin-1-ium | Formula: | C38 H50 N6 O6 S2 | SMILES: | C(NCCOCCOCCOCCNC(CCCCC1SCC2NC(=O)NC12)=O)(C[n+]6c(Cc3cc[n+](C)c4c3cccc4)sc5c6cccc5)=O | InChi: | InChI=1S/C38H48N6O6S2/c1-43-17-14-27(28-8-2-3-9-30(28)43)24-36-44(31-10-4-5-11-32(31)52-36)25-35(46)40-16-19-49-21-23-50-22-20-48-18-15-39-34(45)13-7-6-12-33-37-29(26-51-33)41-38(47)42-37/h2-5,8-11,14,17,29,33,37H,6-7,12-13,15-16,18-26H2,1H3,(H2-2,39,40,41,42,45,46,47)/p+2/t29-,33-,37-/m1/s1 | Definition date: | 2018-07-31 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | 4-[(3-{2,16-dioxo-20-[(3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-6,9,12-trioxa-3,15-diazaicosan-1-yl}-1,3-benzothiazol-3-ium-2-yl)methyl]-1-methylquinolin-1-ium |
|
![HZG HZG](https://data.pdbj.org/pdbjplus/data/cc/svg/HZG.svg) | HZG | Name: | 1-methyl-4-{[3-(2-oxopropyl)-1,3-benzothiazol-3-ium-2-yl]methyl}quinolin-1-ium | Formula: | C21 H20 N2 O S | SMILES: | c3cc(Cc1[n+](CC(C)=O)c2c(s1)cccc2)c4c([n+]3C)cccc4 | InChi: | InChI=1S/C21H20N2OS/c1-15(24)14-23-19-9-5-6-10-20(19)25-21(23)13-16-11-12-22(2)18-8-4-3-7-17(16)18/h3-12H,13-14H2,1-2H3/q+2 | Definition date: | 2018-07-31 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | 1-methyl-4-{[3-(2-oxopropyl)-1,3-benzothiazol-3-ium-2-yl]methyl}quinolin-1-ium |
|
![J0K J0K](https://data.pdbj.org/pdbjplus/data/cc/svg/J0K.svg) | J0K | Name: | 4-[2-(9-chloranyl-2',3',4',5',6'-pentamethyl-4-oxidanyl-7-oxidanylidene-spiro[1$l^{4},8-diaza-9$l^{8}-iridabicyclo[4.3.0]nona-1(6),2,4-triene-9,1'-1$l^{8}-iridapentacyclo[2.2.0.0^{1,3}.0^{1,5}.0^{2,6}]hexane]-8-yl)ethyl]benzenesulfonamide | Formula: | C24 H29 Cl Ir N3 O4 S | SMILES: | CC1C(C)C(C)C(C)C1C.N[S](=O)(=O)c2ccc(CCN([Ir]Cl)C(=O)c3cc(O)ccn3)cc2 | InChi: | InChI=1S/C14H15N3O4S.C10H15.ClH.Ir/c15-22(20,21)12-3-1-10(2-4-12)5-7-17-14(19)13-9-11(18)6-8-16-13 | Definition date: | 2019-01-10 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | 4-[2-(9-chloranyl-2',3',4',5',6'-pentamethyl-4-oxidanyl-7-oxidanylidene-spiro[1$l^{4},8-diaza-9$l^{8}-iridabicyclo[4.3.0]nona-1(6),2,4-triene-9,1'-1$l^{8}-iridapentacyclo[2.2.0.0^{1,3}.0^{1,5}.0^{2,6}]hexane]-8-yl)ethyl]benzenesulfonamide |
|
![J0N J0N](https://data.pdbj.org/pdbjplus/data/cc/svg/J0N.svg) | J0N | Name: | 4-[2-(9-chloranyl-2',3',4',5',6'-pentamethyl-7-oxidanylidene-spiro[1$l^{4},8-diaza-9$l^{8}-iridabicyclo[4.3.0]nona-1(6),2,4-triene-9,1'-1$l^{8}-iridapentacyclo[2.2.0.0^{1,3}.0^{1,5}.0^{2,6}]hexane]-8-yl)ethyl]benzenesulfonamide | Formula: | C24 H29 Cl Ir N3 O3 S | SMILES: | CC1C(C)C(C)C(C)C1C.N[S](=O)(=O)c2ccc(CCN([Ir]Cl)C(=O)c3ccccn3)cc2 | InChi: | InChI=1S/C14H15N3O3S.C10H15.ClH.Ir/c15-21(19,20)12-6-4-11(5-7-12)8-10-17-14(18)13-3-1-2-9-16-13 | Definition date: | 2019-01-10 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | 4-[2-(9-chloranyl-2',3',4',5',6'-pentamethyl-7-oxidanylidene-spiro[1$l^{4},8-diaza-9$l^{8}-iridabicyclo[4.3.0]nona-1(6),2,4-triene-9,1'-1$l^{8}-iridapentacyclo[2.2.0.0^{1,3}.0^{1,5}.0^{2,6}]hexane]-8-yl)ethyl]benzenesulfonamide |
|
![GTV GTV](https://data.pdbj.org/pdbjplus/data/cc/svg/GTV.svg) | GTV | Name: | [(5,7-dimethyl-2-oxo-2H-1-benzopyran-4-yl)methyl]phosphonic acid | Formula: | C12 H13 O5 P | SMILES: | Cc2cc(C)c1C(CP(O)(O)=O)=CC(=O)Oc1c2 | InChi: | InChI=1S/C12H13O5P/c1-7-3-8(2)12-9(6-18(14,15)16)5-11(13)17-10(12)4-7/h3-5H,6H2,1-2H3,(H2,14,15,16) | Definition date: | 2018-04-17 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | [(5,7-dimethyl-2-oxo-2H-1-benzopyran-4-yl)methyl]phosphonic acid |
|
![GUJ GUJ](https://data.pdbj.org/pdbjplus/data/cc/svg/GUJ.svg) | GUJ | Name: | 3-benzyl-2,9-dimethyl-4H,6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,4]oxazepine | Formula: | C17 H17 N3 O S | SMILES: | c3(nnc4COCc1c(sc(c1Cc2ccccc2)C)n34)C | InChi: | InChI=1S/C17H17N3OS/c1-11-14(8-13-6-4-3-5-7-13)15-9-21-10-16-19-18-12(2)20(16)17(15)22-11/h3-7H,8-10H2,1-2H3 | Definition date: | 2018-06-01 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | 3-benzyl-2,9-dimethyl-4H,6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,4]oxazepine |
|
![GXH GXH](https://data.pdbj.org/pdbjplus/data/cc/svg/GXH.svg) | GXH | Name: | 3-(2,5-dimethoxyphenyl)-~{N}-[4-[4-(4-fluorophenyl)-2-(2-phenylhydrazinyl)-1,3-thiazol-5-yl]pyridin-2-yl]propanamide | Formula: | C31 H28 F N5 O3 S | SMILES: | COc1ccc(OC)c(CCC(=O)Nc2cc(ccn2)c3sc(NNc4ccccc4)nc3c5ccc(F)cc5)c1 | InChi: | InChI=1S/C31H28FN5O3S/c1-39-25-13-14-26(40-2)21(18-25)10-15-28(38)34-27-19-22(16-17-33-27)30-29(20-8-11-23(32)12-9-20)35-31(41-30)37-36-24-6-4-3-5-7-24/h3-9,11-14,16-19,36H,10,15H2,1-2H3,(H,35,37)(H,33,34,38) | Definition date: | 2018-10-16 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | 3-(2,5-dimethoxyphenyl)-~{N}-[4-[4-(4-fluorophenyl)-2-(2-phenylhydrazinyl)-1,3-thiazol-5-yl]pyridin-2-yl]propanamide |
|
![GE5 GE5](https://data.pdbj.org/pdbjplus/data/cc/svg/GE5.svg) | GE5 | Name: | 3-(2,5-dimethoxyphenyl)-~{N}-[4-[4-(4-fluorophenyl)-2-[(~{E})-phenyldiazenyl]-1,3-thiazol-5-yl]pyridin-2-yl]propanamide | Formula: | C31 H26 F N5 O3 S | SMILES: | COc1ccc(OC)c(CCC(=O)Nc2cc(ccn2)c3sc(N=Nc4ccccc4)nc3c5ccc(F)cc5)c1 | InChi: | InChI=1S/C31H26FN5O3S/c1-39-25-13-14-26(40-2)21(18-25)10-15-28(38)34-27-19-22(16-17-33-27)30-29(20-8-11-23(32)12-9-20)35-31(41-30)37-36-24-6-4-3-5-7-24/h3-9,11-14,16-19H,10,15H2,1-2H3,(H,33,34,38)/b37-36+ | Definition date: | 2018-09-13 | Last modified: | 2019-04-12 | Release date: | 2019-04-17 | Identifier: | 3-(2,5-dimethoxyphenyl)-~{N}-[4-[4-(4-fluorophenyl)-2-[(~{E})-phenyldiazenyl]-1,3-thiazol-5-yl]pyridin-2-yl]propanamide |
|